CHOSA — Chosa Oncology AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK64.74m
- SEK55.97m
- SEK0.07m
Annual cashflow statement for Chosa Oncology AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.5 | -47.5 | -61.9 | -41.1 | -23.5 |
| Non-Cash Items | 0.055 | 0 | — | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.89 | -3.03 | 12.7 | 10.2 | 39.8 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -42.3 | -50.5 | -49.1 | -30.9 | 16.3 |
| Other Investing Cash Flow Items | — | — | — | — | 0 |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | — | — | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 155 | 0.014 | 0.47 | 15 | -8.52 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 113 | -52 | -47.9 | -14.5 | 7.81 |